tradingkey.logo

Ekso Bionics Holdings Inc

EKSO
查看详细走势图
4.860USD
+0.040+0.83%
收盘 12/19, 16:00美东报价延迟15分钟
12.75M总市值
亏损市盈率 TTM

Ekso Bionics Holdings Inc

4.860
+0.040+0.83%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.83%

5天

+4.07%

1月

+25.58%

6月

+68.75%

今年开始到现在

-46.89%

1年

-44.15%

查看详细走势图

TradingKey Ekso Bionics Holdings Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Ekso Bionics Holdings Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名77/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价7.75。中期看,股价处于平稳状态。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Ekso Bionics Holdings Inc评分

相关信息

行业排名
77 / 208
全市场排名
188 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 2 位分析师
买入
评级
7.750
目标均价
+75.34%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Ekso Bionics Holdings Inc亮点

亮点风险
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
业绩高增长
公司营业收入稳步增长,连续3年增长38.82%
业绩增长期
公司处于发展阶段,最新年度总收入17.93M美元
估值高估
公司最新PE估值-0.90,处于3年历史高位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值35.45K

Ekso Bionics Holdings Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Ekso Bionics Holdings Inc简介

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
公司代码EKSO
公司Ekso Bionics Holdings Inc
CEODavis (Scott G)
网址https://eksobionics.com/

常见问题

Ekso Bionics Holdings Inc(EKSO)的当前股价是多少?

Ekso Bionics Holdings Inc(EKSO)的当前股价是 4.860。

Ekso Bionics Holdings Inc的股票代码是什么?

Ekso Bionics Holdings Inc的股票代码是EKSO。

Ekso Bionics Holdings Inc股票的52周最高点是多少?

Ekso Bionics Holdings Inc股票的52周最高点是14.975。

Ekso Bionics Holdings Inc股票的52周最低点是多少?

Ekso Bionics Holdings Inc股票的52周最低点是2.730。

Ekso Bionics Holdings Inc的市值是多少?

Ekso Bionics Holdings Inc的市值是12.75M。

Ekso Bionics Holdings Inc的净利润是多少?

Ekso Bionics Holdings Inc的净利润为-11.33M。

现在Ekso Bionics Holdings Inc(EKSO)的股票是买入、持有还是卖出?

根据分析师评级,Ekso Bionics Holdings Inc(EKSO)的总体评级为买入,目标价格为7.750。

Ekso Bionics Holdings Inc(EKSO)股票的每股收益(EPS TTM)是多少

Ekso Bionics Holdings Inc(EKSO)股票的每股收益(EPS TTM)是-5.410。
KeyAI